ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag minorities culture disease medicine

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Image of pancreatic organoids under a microscope with immunofluorescent staining
Pancreatic Organoids Take the Stage
Laura Tran, PhD | Dec 1, 2023 | 2 min read
Meritxell Huch tackled her pipedream of growing three-dimensional pancreatic tissue in a dish.
a newly hatched mosquito sits on top of water, with its discarded cocoon floating below
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
Katherine Irving | Jan 20, 2023 | 4 min read
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say.
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Brain cell in purple on a black background. Arc mRNAs are labeled green and are mainly localized in the cell nucleus and in the dendrites.
Short-lived Molecules Support Long-term Memory 
Alejandra Manjarrez, PhD | Jun 6, 2023 | 3 min read
A gene essential for information storage in the brain engages an autoregulatory feedback loop to consolidate memory.
a false color transmission electron microscope image of a neuronal cell body, with lysosomes colored dark green
Scientists Uncover Major Pathway Cells Use to Mend Leaky Lysosomes
Holly Barker, PhD | Oct 6, 2022 | 3 min read
Damaged lysosomes are repaired by a lipid-based signaling pathway dubbed PITT that could be targeted to treat neurodegenerative disease, its discoverers say.
On Race and Medicine
Keith Norris | Feb 1, 2014 | 4 min read
Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.
academic biomedical research pharmaceutical conflict of interest
Opinion: The “Money Culture” in Academic Biomedical Research
David Rubenson | Mar 29, 2019 | 4 min read
A drive for revenue is damaging basic science.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
Amid Criticism, NCI Tries To Boost Minority Clinical-Trial Recruitment
Myrna Watanabe | Apr 1, 1996 | 10+ min read
Clinical-Trial Recruitment 'PLEASANT SUPRISE': NCI's Otis Brawley notes the racial makeup of treatment-trial patients was not planned. The National Cancer Institute (NCI), the largest of the National Institutes of Health, proudly touts its record of recruiting minorities into clinical trials it supports. "We have incredibly good representation of minorities on treatment trials," maintains Otis Brawley, senior investigator in the Community Oncology and Rehabilitation Branch of NCI's Division o

Run a Search

ADVERTISEMENT